Precision Biosciences Inc
DTIL
Loading quote...
Financials
| 52Week High | 13.44 | 52Week Low | 3.61 |
| Beta | 1.55 | Current Ratio Annual | 6.34 |
| Current Ratio Quarterly | 6.62 | Market Cap | 50.78M |
| Net Profit Margin TTM | -42.99 | Operating Margin TTM | -86.21 |
| Price To Book | 1.03 | Price To Sales TTM | 0.99 |
| Quick Ratio Annual | 5.91 | Quick Ratio Quarterly | 6.25 |
| Return On Assets TTM | -15.17 | Return On Equity TTM | -35.85 |
| Return On Investment TTM | -26.27 | Revenue Growth3Y | -15.91 |
| Revenue Growth5Y | 25.30 | Revenue Growth Quarterly Yoy | -99.84 |
| Revenue Growth TTMYoy | -11.11 | Revenue Per Share TTM | 5.50 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 56 | 1 | 0 | 2 | 1 | 1 | 3.79M | $13.37M |
| Mar 31, 2025 | 49(-13%) | 7(+600%) | 8(+%) | 9(+350%) | 10(+900%) | 22(+2100%) | 3.74M(-1%) | $16.49M(+23%) |
| Jun 30, 2025 | 50(+2%) | 8(+14%) | 7(-13%) | 14(+56%) | 7(-30%) | 18(-18%) | 4.42M(+18%) | $17.40M(+6%) |